Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin.
about
Cancer-associated thrombotic microangiopathyThe behavior of matrix metalloproteinases and their inhibitors in colorectal cancerA systematic evaluation of laboratory testing for drug-induced immune thrombocytopeniaLife-threatening oxaliplatin-induced acute thrombocytopenia, hemolysis and bleeding: a case report.Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and managementDrug-induced thrombocytopenia: pathogenesis, evaluation, and management.Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature.A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group studyOxaliplatin-induced acute thrombocytopenia.Acute thrombocytopenia: an unusual complication occurring after drug-eluting microspheres transcatheter hepatic chemoembolization.Thrombocytopenia in adult cancer patients receiving cytotoxic chemotherapy: results from a retrospective hospital-based cohort study.Oxaliplatin-related thrombocytopenia.Oxaliplatin-induced acute-onset thrombocytopenia and hemorrhage: Case report and review of the literatureOxaliplatin induced disseminated intravascular coagulation: A case report and review of literatureLaparoscopic Splenectomy in Colorectal Cancer Patients with Chemotherapy-Associated Thrombocytopenia due to Hypersplenism.Hemophagocytic syndrome: an unusual and underestimated complication of cytoreduction surgery with heated intraperitoneal oxaliplatin.Drug-induced thrombocytopenia in children.Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.Irinotecan-induced immune thrombocytopenia.Oxaliplatin-induced immune-mediated cytopenias: a case report and literature review.A case of oxaliplatin-induced immune-mediated thrombocytopenia.A 39-year-old female patient with metastatic rectal cancer develops thrombocytopenia.Antiplatelet antibodies in oxaliplatin-induced immune thrombocytopenia.Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case ReportOxaliplatin-induced acute renal failure presenting clinically as thrombotic microangiopathy: think of acute tubular necrosis.Drug-Immune Thrombocytopenia with Thrombosis versus Heparin-Induced Thrombocytopenia: A Critical Clinical Controversy.Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis.Oxaliplatin-induced hypersensitivity reaction: underlying mechanisms and management.Hypersensitivity reactions associated with oxaliplatin and their clinical management.Presentation and Diagnosis of Hypersensitivity to Platinum Drugs.Acute drop of platelets in metastatic colon cancer.Pharmacokinetic and toxicodynamic evaluation of oxaliplatin-induced neuropathy and hematological toxicity in rats.A patient with oxaliplatin immune-induced syndrome (OIIS) who also developed leucovorin and palonosetron-associated thrombocytopenia.Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodies.
P2860
Q26738984-232E7EEF-0578-4FDA-9752-A1435F8E9BADQ27004958-466B7733-39EE-49AE-BEAC-A7388B2B16C2Q27686838-E71F771D-5BAC-42C0-95F8-8744677CFFF5Q33380253-5A194E26-AC07-4BC7-9BF5-6406FDD5C500Q33384003-D5298845-8662-4FE8-9FE4-DCE862889D8AQ33387498-C706C8E8-684E-4094-8371-83439212E1FAQ33388956-D6E7438E-44D0-412A-A59E-45EBB6FB3CD8Q33390957-35B9D9D8-7805-4A1A-BC8A-AA4DD8198F75Q33391330-7B29CCF5-3783-41C3-8350-474739301533Q33391916-41C57CDE-5270-4019-82A7-5914BDE7F0BAQ33398191-97AC0750-ECF1-466D-9746-99496605127AQ33400936-1826314F-971C-4548-A92F-FE4C8A2049BAQ33402268-E0DBF960-7B13-4985-9A90-537C5B34C3F8Q33402578-9BC21982-1A3F-4BB4-AC56-09923B8237E3Q33405026-943E05B3-03FC-4CFB-947F-7DC554F6A043Q33408999-3B09E6B8-0129-40DE-9C1B-FC6E83C6B67AQ33410359-E837B1A5-0789-4A03-92C1-BA751D4C223BQ33410375-34286335-2C57-4F84-B1C7-3A6033F6A200Q33412997-766358E2-F1F6-4B19-8766-F5977E3929BAQ33413179-C1D35492-6931-4C1A-8E7F-7D3B086C50D6Q33414565-ED113FF7-A91D-4CA2-AF21-9CE1BB820FB4Q33415092-45AAFF2F-522A-48CF-81B2-10A937163645Q33416698-AABAC0C0-8DFB-43AA-A547-5FB4A1B9E554Q33419508-2CF29562-4301-404A-ADAC-79D094015B92Q33422905-931242C6-BE96-44AB-972C-BDA7D26AD69CQ33425127-A1595393-5610-434D-AE7A-DB976AB7C104Q36316717-10656F19-341A-4090-A586-9ADE5EC86D01Q38237316-79DEF5EF-606A-4073-ABF9-3844D0107C4FQ38259295-F52833CE-7442-4DB1-8A26-638FD6A5B49EQ38541188-511D32B9-70A2-421F-922A-A2D4970AA733Q45800296-1E2484FC-AA26-49DF-8D0A-B5401A96E0FEQ47430728-98C81FA0-0C43-4CA3-AB7A-0473FF27C258Q49549984-7D91375F-F28E-4D89-AD40-CAF86AEC41EDQ50028367-A0DAC75D-6D05-4C9C-B244-DF175E5FCA0C
P2860
Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin.
@ast
Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin.
@en
type
label
Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin.
@ast
Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin.
@en
prefLabel
Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin.
@ast
Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin.
@en
P2093
P356
P1476
Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin.
@en
P2093
Brian R Curtis
James Kaliszewski
Janice G McFarland
Jules Blank
Lisle Nabelle
M Wasif Saif
Richard H Aster
P304
P356
10.1002/AJH.20516
P577
2006-03-01T00:00:00Z